nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Risedronate—PTGS2—muscle cancer	0.0154	0.529	CrCbGaD
Pamidronate—Clodronate—PTGS2—muscle cancer	0.0137	0.471	CrCbGaD
Pamidronate—FDPS—smooth muscle tissue—muscle cancer	0.00287	0.16	CbGeAlD
Pamidronate—FDPS—renal system—muscle cancer	0.00276	0.154	CbGeAlD
Pamidronate—Anaphylactic shock—Vincristine—muscle cancer	0.00261	0.00274	CcSEcCtD
Pamidronate—Oedema—Vincristine—muscle cancer	0.00261	0.00274	CcSEcCtD
Pamidronate—Infection—Vincristine—muscle cancer	0.00259	0.00272	CcSEcCtD
Pamidronate—Phlebitis—Doxorubicin—muscle cancer	0.00259	0.00271	CcSEcCtD
Pamidronate—Thrombophlebitis—Doxorubicin—muscle cancer	0.00257	0.0027	CcSEcCtD
Pamidronate—Osteoarthritis—Methotrexate—muscle cancer	0.00257	0.0027	CcSEcCtD
Pamidronate—Nervous system disorder—Vincristine—muscle cancer	0.00256	0.00268	CcSEcCtD
Pamidronate—Thrombocytopenia—Vincristine—muscle cancer	0.00255	0.00268	CcSEcCtD
Pamidronate—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00255	0.00268	CcSEcCtD
Pamidronate—Decreased appetite—Dactinomycin—muscle cancer	0.00254	0.00266	CcSEcCtD
Pamidronate—Dysgeusia—Etoposide—muscle cancer	0.00253	0.00266	CcSEcCtD
Pamidronate—Hyperhidrosis—Vincristine—muscle cancer	0.00252	0.00264	CcSEcCtD
Pamidronate—Fatigue—Dactinomycin—muscle cancer	0.00252	0.00264	CcSEcCtD
Pamidronate—Back pain—Etoposide—muscle cancer	0.0025	0.00263	CcSEcCtD
Pamidronate—Pain—Dactinomycin—muscle cancer	0.00249	0.00262	CcSEcCtD
Pamidronate—Muscle spasms—Etoposide—muscle cancer	0.00249	0.00261	CcSEcCtD
Pamidronate—Anorexia—Vincristine—muscle cancer	0.00248	0.00261	CcSEcCtD
Pamidronate—FDPS—cardiac atrium—muscle cancer	0.00247	0.138	CbGeAlD
Pamidronate—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00246	0.00258	CcSEcCtD
Pamidronate—Hypotension—Vincristine—muscle cancer	0.00244	0.00256	CcSEcCtD
Pamidronate—Renal failure acute—Doxorubicin—muscle cancer	0.00241	0.00253	CcSEcCtD
Pamidronate—Feeling abnormal—Dactinomycin—muscle cancer	0.0024	0.00252	CcSEcCtD
Pamidronate—Ill-defined disorder—Etoposide—muscle cancer	0.0024	0.00252	CcSEcCtD
Pamidronate—Anaemia—Etoposide—muscle cancer	0.00239	0.00251	CcSEcCtD
Pamidronate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00239	0.0025	CcSEcCtD
Pamidronate—Liver function test abnormal—Methotrexate—muscle cancer	0.00238	0.00249	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00237	0.00249	CcSEcCtD
Pamidronate—Insomnia—Vincristine—muscle cancer	0.00236	0.00247	CcSEcCtD
Pamidronate—Paraesthesia—Vincristine—muscle cancer	0.00234	0.00246	CcSEcCtD
Pamidronate—Malaise—Etoposide—muscle cancer	0.00233	0.00245	CcSEcCtD
Pamidronate—Leukopenia—Etoposide—muscle cancer	0.00232	0.00243	CcSEcCtD
Pamidronate—Abdominal pain—Dactinomycin—muscle cancer	0.00231	0.00242	CcSEcCtD
Pamidronate—Body temperature increased—Dactinomycin—muscle cancer	0.00231	0.00242	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.0023	0.00242	CcSEcCtD
Pamidronate—Cardiac failure—Doxorubicin—muscle cancer	0.00228	0.0024	CcSEcCtD
Pamidronate—Loss of consciousness—Etoposide—muscle cancer	0.00227	0.00239	CcSEcCtD
Pamidronate—Lethargy—Doxorubicin—muscle cancer	0.00227	0.00239	CcSEcCtD
Pamidronate—Decreased appetite—Vincristine—muscle cancer	0.00227	0.00238	CcSEcCtD
Pamidronate—Cough—Etoposide—muscle cancer	0.00226	0.00237	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Vincristine—muscle cancer	0.00225	0.00236	CcSEcCtD
Pamidronate—Fatigue—Vincristine—muscle cancer	0.00225	0.00236	CcSEcCtD
Pamidronate—Convulsion—Etoposide—muscle cancer	0.00224	0.00235	CcSEcCtD
Pamidronate—Hypertension—Etoposide—muscle cancer	0.00223	0.00234	CcSEcCtD
Pamidronate—Pain—Vincristine—muscle cancer	0.00223	0.00234	CcSEcCtD
Pamidronate—Constipation—Vincristine—muscle cancer	0.00223	0.00234	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00223	0.00234	CcSEcCtD
Pamidronate—Osteoarthritis—Doxorubicin—muscle cancer	0.00223	0.00234	CcSEcCtD
Pamidronate—Discomfort—Etoposide—muscle cancer	0.00218	0.00228	CcSEcCtD
Pamidronate—FDPS—tendon—muscle cancer	0.00215	0.12	CbGeAlD
Pamidronate—Hypersensitivity—Dactinomycin—muscle cancer	0.00215	0.00226	CcSEcCtD
Pamidronate—Gastrointestinal pain—Vincristine—muscle cancer	0.00213	0.00224	CcSEcCtD
Pamidronate—Confusional state—Etoposide—muscle cancer	0.00213	0.00223	CcSEcCtD
Pamidronate—Anaphylactic shock—Etoposide—muscle cancer	0.00211	0.00222	CcSEcCtD
Pamidronate—Infection—Etoposide—muscle cancer	0.0021	0.0022	CcSEcCtD
Pamidronate—Asthenia—Dactinomycin—muscle cancer	0.00209	0.0022	CcSEcCtD
Pamidronate—Blood creatinine increased—Doxorubicin—muscle cancer	0.00209	0.00219	CcSEcCtD
Pamidronate—FDPS—bone marrow—muscle cancer	0.00209	0.116	CbGeAlD
Pamidronate—Neutropenia—Methotrexate—muscle cancer	0.00208	0.00218	CcSEcCtD
Pamidronate—Thrombocytopenia—Etoposide—muscle cancer	0.00207	0.00217	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00207	0.00217	CcSEcCtD
Pamidronate—Tachycardia—Etoposide—muscle cancer	0.00206	0.00216	CcSEcCtD
Pamidronate—Abdominal pain—Vincristine—muscle cancer	0.00206	0.00216	CcSEcCtD
Pamidronate—Body temperature increased—Vincristine—muscle cancer	0.00206	0.00216	CcSEcCtD
Pamidronate—Liver function test abnormal—Doxorubicin—muscle cancer	0.00206	0.00216	CcSEcCtD
Pamidronate—Hyperhidrosis—Etoposide—muscle cancer	0.00204	0.00214	CcSEcCtD
Pamidronate—Hypokalaemia—Doxorubicin—muscle cancer	0.00203	0.00213	CcSEcCtD
Pamidronate—Anorexia—Etoposide—muscle cancer	0.00201	0.00211	CcSEcCtD
Pamidronate—FDPS—vagina—muscle cancer	0.002	0.111	CbGeAlD
Pamidronate—Diarrhoea—Dactinomycin—muscle cancer	0.002	0.00209	CcSEcCtD
Pamidronate—Pneumonia—Methotrexate—muscle cancer	0.00199	0.00209	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—muscle cancer	0.00199	0.00209	CcSEcCtD
Pamidronate—Infestation NOS—Methotrexate—muscle cancer	0.00198	0.00208	CcSEcCtD
Pamidronate—Infestation—Methotrexate—muscle cancer	0.00198	0.00208	CcSEcCtD
Pamidronate—Hypotension—Etoposide—muscle cancer	0.00197	0.00207	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—muscle cancer	0.00197	0.00207	CcSEcCtD
Pamidronate—Renal failure—Methotrexate—muscle cancer	0.00195	0.00205	CcSEcCtD
Pamidronate—Stomatitis—Methotrexate—muscle cancer	0.00193	0.00203	CcSEcCtD
Pamidronate—Conjunctivitis—Methotrexate—muscle cancer	0.00193	0.00202	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—muscle cancer	0.00193	0.00202	CcSEcCtD
Pamidronate—Hypersensitivity—Vincristine—muscle cancer	0.00192	0.00202	CcSEcCtD
Pamidronate—Paraesthesia—Etoposide—muscle cancer	0.0019	0.00199	CcSEcCtD
Pamidronate—Haematuria—Methotrexate—muscle cancer	0.00189	0.00198	CcSEcCtD
Pamidronate—Dyspnoea—Etoposide—muscle cancer	0.00188	0.00198	CcSEcCtD
Pamidronate—Somnolence—Etoposide—muscle cancer	0.00188	0.00197	CcSEcCtD
Pamidronate—Asthenia—Vincristine—muscle cancer	0.00187	0.00196	CcSEcCtD
Pamidronate—Vomiting—Dactinomycin—muscle cancer	0.00185	0.00195	CcSEcCtD
Pamidronate—Agranulocytosis—Methotrexate—muscle cancer	0.00185	0.00194	CcSEcCtD
Pamidronate—FDPS—head—muscle cancer	0.00185	0.103	CbGeAlD
Pamidronate—Rash—Dactinomycin—muscle cancer	0.00184	0.00193	CcSEcCtD
Pamidronate—Decreased appetite—Etoposide—muscle cancer	0.00184	0.00193	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00182	0.00191	CcSEcCtD
Pamidronate—Fatigue—Etoposide—muscle cancer	0.00182	0.00191	CcSEcCtD
Pamidronate—Pain—Etoposide—muscle cancer	0.00181	0.00189	CcSEcCtD
Pamidronate—Constipation—Etoposide—muscle cancer	0.00181	0.00189	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—muscle cancer	0.0018	0.00189	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00179	0.00188	CcSEcCtD
Pamidronate—Haemoglobin—Methotrexate—muscle cancer	0.00179	0.00188	CcSEcCtD
Pamidronate—FDPS—testis—muscle cancer	0.00178	0.0993	CbGeAlD
Pamidronate—Diarrhoea—Vincristine—muscle cancer	0.00178	0.00187	CcSEcCtD
Pamidronate—Haemorrhage—Methotrexate—muscle cancer	0.00178	0.00187	CcSEcCtD
Pamidronate—Urinary tract disorder—Methotrexate—muscle cancer	0.00176	0.00184	CcSEcCtD
Pamidronate—Urethral disorder—Methotrexate—muscle cancer	0.00175	0.00183	CcSEcCtD
Pamidronate—Feeling abnormal—Etoposide—muscle cancer	0.00174	0.00183	CcSEcCtD
Pamidronate—Nausea—Dactinomycin—muscle cancer	0.00173	0.00182	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—muscle cancer	0.00173	0.00181	CcSEcCtD
Pamidronate—Gastrointestinal pain—Etoposide—muscle cancer	0.00173	0.00181	CcSEcCtD
Pamidronate—Dizziness—Vincristine—muscle cancer	0.00172	0.00181	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—muscle cancer	0.00172	0.0018	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—muscle cancer	0.00172	0.0018	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—muscle cancer	0.00169	0.00177	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—muscle cancer	0.00167	0.00176	CcSEcCtD
Pamidronate—Abdominal pain—Etoposide—muscle cancer	0.00167	0.00175	CcSEcCtD
Pamidronate—Body temperature increased—Etoposide—muscle cancer	0.00167	0.00175	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—muscle cancer	0.00167	0.00175	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—muscle cancer	0.00167	0.00175	CcSEcCtD
Pamidronate—Eye disorder—Methotrexate—muscle cancer	0.00166	0.00175	CcSEcCtD
Pamidronate—Vomiting—Vincristine—muscle cancer	0.00166	0.00174	CcSEcCtD
Pamidronate—Cardiac disorder—Methotrexate—muscle cancer	0.00165	0.00173	CcSEcCtD
Pamidronate—Rash—Vincristine—muscle cancer	0.00164	0.00172	CcSEcCtD
Pamidronate—Dermatitis—Vincristine—muscle cancer	0.00164	0.00172	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—muscle cancer	0.00164	0.00172	CcSEcCtD
Pamidronate—Headache—Vincristine—muscle cancer	0.00163	0.00171	CcSEcCtD
Pamidronate—Angiopathy—Methotrexate—muscle cancer	0.00162	0.00169	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—muscle cancer	0.00161	0.00169	CcSEcCtD
Pamidronate—Immune system disorder—Methotrexate—muscle cancer	0.00161	0.00169	CcSEcCtD
Pamidronate—Mediastinal disorder—Methotrexate—muscle cancer	0.0016	0.00168	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—muscle cancer	0.0016	0.00168	CcSEcCtD
Pamidronate—Chills—Methotrexate—muscle cancer	0.0016	0.00168	CcSEcCtD
Pamidronate—Alopecia—Methotrexate—muscle cancer	0.00157	0.00165	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—muscle cancer	0.00156	0.00163	CcSEcCtD
Pamidronate—Malnutrition—Methotrexate—muscle cancer	0.00155	0.00163	CcSEcCtD
Pamidronate—Erythema—Methotrexate—muscle cancer	0.00155	0.00163	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—muscle cancer	0.00155	0.00163	CcSEcCtD
Pamidronate—Nausea—Vincristine—muscle cancer	0.00155	0.00162	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—muscle cancer	0.00155	0.00162	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—muscle cancer	0.00154	0.00162	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—muscle cancer	0.00152	0.0016	CcSEcCtD
Pamidronate—Dysgeusia—Methotrexate—muscle cancer	0.00152	0.00159	CcSEcCtD
Pamidronate—Asthenia—Etoposide—muscle cancer	0.00151	0.00159	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—muscle cancer	0.00151	0.00159	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—muscle cancer	0.00151	0.00159	CcSEcCtD
Pamidronate—Back pain—Methotrexate—muscle cancer	0.0015	0.00157	CcSEcCtD
Pamidronate—Pruritus—Etoposide—muscle cancer	0.00149	0.00157	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—muscle cancer	0.00144	0.00152	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—muscle cancer	0.00144	0.00151	CcSEcCtD
Pamidronate—Ill-defined disorder—Methotrexate—muscle cancer	0.00144	0.00151	CcSEcCtD
Pamidronate—Anaemia—Methotrexate—muscle cancer	0.00143	0.0015	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—muscle cancer	0.00143	0.0015	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—muscle cancer	0.00143	0.0015	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—muscle cancer	0.0014	0.00147	CcSEcCtD
Pamidronate—Malaise—Methotrexate—muscle cancer	0.0014	0.00147	CcSEcCtD
Pamidronate—Dizziness—Etoposide—muscle cancer	0.0014	0.00147	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—muscle cancer	0.00139	0.00146	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—muscle cancer	0.00139	0.00146	CcSEcCtD
Pamidronate—Leukopenia—Methotrexate—muscle cancer	0.00139	0.00146	CcSEcCtD
Pamidronate—Chills—Doxorubicin—muscle cancer	0.00138	0.00145	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—muscle cancer	0.00136	0.00143	CcSEcCtD
Pamidronate—Cough—Methotrexate—muscle cancer	0.00135	0.00142	CcSEcCtD
Pamidronate—Convulsion—Methotrexate—muscle cancer	0.00134	0.00141	CcSEcCtD
Pamidronate—Vomiting—Etoposide—muscle cancer	0.00134	0.00141	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—muscle cancer	0.00134	0.00141	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—muscle cancer	0.00134	0.00141	CcSEcCtD
Pamidronate—Rash—Etoposide—muscle cancer	0.00133	0.0014	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—muscle cancer	0.00133	0.0014	CcSEcCtD
Pamidronate—Headache—Etoposide—muscle cancer	0.00132	0.00139	CcSEcCtD
Pamidronate—Myalgia—Methotrexate—muscle cancer	0.00132	0.00138	CcSEcCtD
Pamidronate—Arthralgia—Methotrexate—muscle cancer	0.00132	0.00138	CcSEcCtD
Pamidronate—Tension—Doxorubicin—muscle cancer	0.00132	0.00138	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—muscle cancer	0.00131	0.00138	CcSEcCtD
Pamidronate—Discomfort—Methotrexate—muscle cancer	0.0013	0.00137	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—muscle cancer	0.0013	0.00137	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—muscle cancer	0.0013	0.00136	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—muscle cancer	0.00129	0.00135	CcSEcCtD
Pamidronate—Confusional state—Methotrexate—muscle cancer	0.00128	0.00134	CcSEcCtD
Pamidronate—Anaphylactic shock—Methotrexate—muscle cancer	0.00126	0.00133	CcSEcCtD
Pamidronate—Infection—Methotrexate—muscle cancer	0.00126	0.00132	CcSEcCtD
Pamidronate—Nausea—Etoposide—muscle cancer	0.00125	0.00132	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—muscle cancer	0.00125	0.00131	CcSEcCtD
Pamidronate—Nervous system disorder—Methotrexate—muscle cancer	0.00124	0.0013	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—muscle cancer	0.00124	0.0013	CcSEcCtD
Pamidronate—Thrombocytopenia—Methotrexate—muscle cancer	0.00124	0.0013	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—muscle cancer	0.00123	0.00129	CcSEcCtD
Pamidronate—Hyperhidrosis—Methotrexate—muscle cancer	0.00122	0.00128	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—muscle cancer	0.00121	0.00127	CcSEcCtD
Pamidronate—Anorexia—Methotrexate—muscle cancer	0.00121	0.00127	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—muscle cancer	0.0012	0.00126	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—muscle cancer	0.0012	0.00126	CcSEcCtD
Pamidronate—Hypotension—Methotrexate—muscle cancer	0.00118	0.00124	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—muscle cancer	0.00118	0.00124	CcSEcCtD
Pamidronate—Cough—Doxorubicin—muscle cancer	0.00117	0.00123	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—muscle cancer	0.00116	0.00122	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—muscle cancer	0.00116	0.00122	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00115	0.00121	CcSEcCtD
Pamidronate—Insomnia—Methotrexate—muscle cancer	0.00114	0.0012	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—muscle cancer	0.00114	0.0012	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—muscle cancer	0.00114	0.0012	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—muscle cancer	0.00114	0.00119	CcSEcCtD
Pamidronate—Paraesthesia—Methotrexate—muscle cancer	0.00114	0.00119	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—muscle cancer	0.00113	0.00118	CcSEcCtD
Pamidronate—Dyspnoea—Methotrexate—muscle cancer	0.00113	0.00118	CcSEcCtD
Pamidronate—Somnolence—Methotrexate—muscle cancer	0.00112	0.00118	CcSEcCtD
Pamidronate—Dyspepsia—Methotrexate—muscle cancer	0.00111	0.00117	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—muscle cancer	0.0011	0.00116	CcSEcCtD
Pamidronate—Decreased appetite—Methotrexate—muscle cancer	0.0011	0.00115	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—muscle cancer	0.0011	0.00115	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—muscle cancer	0.0011	0.00115	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00109	0.00115	CcSEcCtD
Pamidronate—Fatigue—Methotrexate—muscle cancer	0.00109	0.00114	CcSEcCtD
Pamidronate—Infection—Doxorubicin—muscle cancer	0.00109	0.00114	CcSEcCtD
Pamidronate—Pain—Methotrexate—muscle cancer	0.00108	0.00113	CcSEcCtD
Pamidronate—Shock—Doxorubicin—muscle cancer	0.00108	0.00113	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—muscle cancer	0.00107	0.00113	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—muscle cancer	0.00107	0.00113	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—muscle cancer	0.00107	0.00112	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—muscle cancer	0.00106	0.00111	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—muscle cancer	0.00104	0.0011	CcSEcCtD
Pamidronate—Feeling abnormal—Methotrexate—muscle cancer	0.00104	0.00109	CcSEcCtD
Pamidronate—Gastrointestinal pain—Methotrexate—muscle cancer	0.00103	0.00109	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—muscle cancer	0.00102	0.00107	CcSEcCtD
Pamidronate—Abdominal pain—Methotrexate—muscle cancer	0.001	0.00105	CcSEcCtD
Pamidronate—Body temperature increased—Methotrexate—muscle cancer	0.001	0.00105	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000998	0.00105	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—muscle cancer	0.00099	0.00104	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—muscle cancer	0.000983	0.00103	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—muscle cancer	0.000976	0.00102	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—muscle cancer	0.000974	0.00102	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—muscle cancer	0.000964	0.00101	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—muscle cancer	0.000952	0.000999	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000945	0.000992	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—muscle cancer	0.000944	0.000991	CcSEcCtD
Pamidronate—Pain—Doxorubicin—muscle cancer	0.000936	0.000983	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—muscle cancer	0.000936	0.000983	CcSEcCtD
Pamidronate—Hypersensitivity—Methotrexate—muscle cancer	0.000932	0.000978	CcSEcCtD
Pamidronate—Asthenia—Methotrexate—muscle cancer	0.000907	0.000952	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—muscle cancer	0.000902	0.000947	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000896	0.00094	CcSEcCtD
Pamidronate—Pruritus—Methotrexate—muscle cancer	0.000895	0.000939	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—muscle cancer	0.000866	0.000909	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—muscle cancer	0.000866	0.000909	CcSEcCtD
Pamidronate—Diarrhoea—Methotrexate—muscle cancer	0.000865	0.000908	CcSEcCtD
Pamidronate—Dizziness—Methotrexate—muscle cancer	0.000836	0.000878	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—muscle cancer	0.000807	0.000847	CcSEcCtD
Pamidronate—Vomiting—Methotrexate—muscle cancer	0.000804	0.000844	CcSEcCtD
Pamidronate—Rash—Methotrexate—muscle cancer	0.000797	0.000837	CcSEcCtD
Pamidronate—Dermatitis—Methotrexate—muscle cancer	0.000797	0.000836	CcSEcCtD
Pamidronate—Headache—Methotrexate—muscle cancer	0.000792	0.000831	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—muscle cancer	0.000786	0.000825	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—muscle cancer	0.000775	0.000813	CcSEcCtD
Pamidronate—Nausea—Methotrexate—muscle cancer	0.000751	0.000788	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—muscle cancer	0.000749	0.000786	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—muscle cancer	0.000724	0.00076	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—muscle cancer	0.000696	0.000731	CcSEcCtD
Pamidronate—Rash—Doxorubicin—muscle cancer	0.00069	0.000725	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—muscle cancer	0.00069	0.000724	CcSEcCtD
Pamidronate—Headache—Doxorubicin—muscle cancer	0.000686	0.00072	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—muscle cancer	0.00065	0.000683	CcSEcCtD
